Return to homepagePandemic Pact

IgA for mucosal prophylaxis and treatment of COVID-19

Grant number: J 4583

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    FWF

  • Principal Investigator

    Kathrin GÖRITZER

  • Research Location

    Austria

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Recombinant neutralizing secretory IgA antibodies for preventing mucosal acquisition and transmission of SARS-CoV-2.

Engineering the <i>N</i>-glycosylation pathway of <i>Nicotiana tabacum</i> for molecular pharming using CRISPR/Cas9.